Trade Mark Journal No.2026/040 2 October 2026

UK00004446124 16 September 2026 (5)

RYVIZLA

International priority date claimed: 13 July 2026 (European Union Intellectual Property Office (EUIPO)) (019394660)

Class 5: Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders.

Viridian Therapeutics, Inc.

Representative: Fox Williams LLP